单一治疗Roluperidone,用于治疗精神分裂症的负面症状
Michael Davidson1,2, Nadine Noel3, Florent Schmitt3
1Minerva Neurosciences.
The international journal of neuropsychopharmacology
|May 20, 2025
概括
在抗精神病药物戒断期间,罗卢皮雷有效地改善了精神分裂症患者的原发性负面症状. 这种新的治疗方法在临床试验中表明精神病症状恶化的风险很低.
科学领域:
- 心理药理学 心理药理学
- 神经科学是一个神经科学.
- 临床精神病学 临床精神病学
背景情况:
- 精神分裂症的治疗通常与持续的主要负面症状作斗争.
- 现有的抗精神病药可能无法充分解决负面症状,并可能导致戒断挑战.
- 罗洛利能向特定的受体,这些受体与负面症状有关.
研究的目的:
- 评估罗卢皮里在治疗精神分裂症主要负面症状方面的疗效.
- 评估在抗精神病药物戒断期间的罗卢佩里单一治疗的安全性和耐受性.
- 为了确定roluperidone对这种患者群体中精神病症状稳定性的影响.
主要方法:
- 两项临床试验涉及精神分裂症轻度至中度负面症状的患者.
- 在抗精神病药物停用后,作为单一疗法使用罗卢皮里.
- 在6-9个月的试验期间评估负面症状改善和精神病症状稳定性.
主要成果:
- 罗洛佩里在主要负面症状中显著改善.
- 患者保持了症状稳定,精神病症状恶化的患病率较低.
- 该药物作为单疗法用于从抗精神病药物中断的患者.
结论:
- 罗卢皮里作为针对精神分裂症主要负面症状的向治疗具有前景.
- 它为经历负面症状和接受抗精神病药物戒断的患者提供了潜在的治疗选择.
- 进一步的研究支持了罗卢皮里在管理精神分裂症的特定症状领域中的作用.
相关概念视频
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Psychosis: Goals of Pharmacotherapy
101
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
101
Parkinson's Disease: Treatment
170
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
170
Negative and Cognitive Symptoms of Schizophrenia
39
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
39
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
Psychosis and Antipsychotic Drugs: Overview
167
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
167


